Ticker Details
Structure Therapeutics Inc.
IPO Date:	February 3, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.08B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.41 | 3.74%
Avg Daily Range (30 D):	$1.53 | 3.82%
Avg Daily Range (90 D):	$1.88 | 3.57%

Institutional Daily Volume
Avg Daily Volume:	.77M
Avg Daily Volume (30 D):	.69M
Avg Daily Volume (90 D):	.82M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	2,322
Avg Institutional Trade:	$1.74M
Avg Institutional Trade (30 D):	$1.78M
Avg Institutional Trade (90 D):	$2.11M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$1.95M
Avg Closing Trade (30 D):	$1.9M
Avg Closing Trade (90 D):	$2.62M
Avg Closing Volume:	47.63K

News

May 17, 2026 @ 6:22 PM This Obesity Drug Stock Has Jumped 60% as Phase 3 ... Source: Jonathan Ponciano

Mar 16, 2026 @ 11:00 AM Structure Therapeutics Reports Positive Topline Da... Source: Structure Therapeutics Inc.

Feb 26, 2026 @ 6:35 PM PatentVest Releases New Report on The Oral Small-M... Source: Patentvest

Jan 23, 2026 @ 2:18 PM Weight Loss Drugs Market Is Crowded But Structure ... Source: Vandana Singh

Jan 13, 2026 @ 7:33 PM A 10% Owner Of Structure Therapeutics Shed Shares Source: Adé Hennis

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.88	$-.35	$.2
Diluted EPS	$-.88	$-.35	$.2
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-170.34M	$-75.97M	$33M
Operating Income / Loss	$-209.63M	$-89.38M	$23.99M
Cost of Revenue
Net Cash Flow	$164.05M	$-483.46M	$696.71M
PE Ratio